PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Although PNPLA3 polymorphism is the main genetic risk factor for NAFLD and additionally modulates response to its treatment [8], there have been no studies that have evaluated its role in the development of fatty liver in women with PCOS.